Patents by Inventor Bart Reginald Alfons Winters

Bart Reginald Alfons Winters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DETERMINING THE EFFICACY OF A COMBINATION THERAPY
    Publication number: 20140025310
    Abstract: The present invention concerns the determination of weighted phenotypic sensitivity score (wPSS) for a combination therapy as being the combination of information about the inherent anti-viral potency of each drug, as determined through statistical analysis of response to anti-retroviral therapy combination regimens, with resistance information on the individual patient's virus to each anti-retroviral drug as well as the use of this wPSS for predicting the efficacy of a patient's therapy or for evaluating or optimizing a therapy.
    Type: Application
    Filed: September 18, 2013
    Publication date: January 23, 2014
    Applicant: VIRCO BVBA
    Inventor: Bart Reginald Alfons Winters
  • METHOD FOR DETERMINING THE EFFICACY OF A COMBINATION THERAPY
    Publication number: 20120095739
    Abstract: The present invention concerns the determination of weighted phenotypic sensitivity score (wPSS) for a combination therapy as being the combination of information about the inherent anti-viral potency of each drug, as determined through statistical analysis of response to anti-retroviral therapy combination regimens, with resistance information on the individual patient's virus to each anti-retroviral drug as well as the use of this wPSS for predicting the efficacy of a patient's therapy or for evaluating or optimizing a therapy.
    Type: Application
    Filed: June 30, 2010
    Publication date: April 19, 2012
    Inventor: Bart Reginald Alfons Winters
  • Estimation of clinical cut-offs
    Patent number: 8099262
    Abstract: Methods and systems for improving the accuracy of predicting resistance of a disease to a drug are described. More specifically, methods for assessing the impact of pre-existing variations in drug susceptibility, whether naturally occurring or selected by previous drug exposure, on treatment response in order to establish clinically relevant cut-off values for phenotypic or genotypic resistance tests are described.
    Type: Grant
    Filed: March 1, 2005
    Date of Patent: January 17, 2012
    Assignee: Virco BVBA
    Inventors: Lee Terry Bacheler, Bart Reginald Alfons Winters